Monogram Orthopaedics Inc ( (MGRM) ) has issued an announcement.
Monogram Technologies Inc. has issued a correction to a previous announcement, specifying that they have 180 days to respond to an Additional Information Request from the FDA regarding their mBôs TKA System. This clarification stands as the sole change to the original press release. The company, which focuses on AI-driven robotics for orthopedic surgery, is developing advanced surgical systems and implants to improve patient outcomes, but it must secure FDA clearances before marketing its products.
See more data about MGRM stock on TipRanks’ Stock Analysis page.
